Search research articles
Contact Us
Filters
Showing results (41-50 of 344) with videos related to
Page
of 35
Sort By:
Expert Review of Anticancer Therapy
|
December 5, 2018
Therapeutic potential of trametinib to inhibit the mutagenesis by inactivating the protein kinase pathway in non-small cell lung cancer
Arnaud Jeanson, Arnaud Boyer, Laurent Greillier, et al.
Translational Cancer Research
|
February 4, 2022
First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer
Camille Travert, Pascale Tomasini, Arnaud Jeanson, et al.
Pharmaceutics
|
August 16, 2020
Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Guillaume Sicard, Frédéric Fina, Raphaelle Fanciullino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2015
Ang1 and Tie2 are predictive biomarkers for bevacizumab-letter
Joseph Ciccolini, Cindy Serdjebi, Dominique Barbolosi, et al.
Therapeutic Advances in Respiratory Disease
|
February 22, 2019
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases
Pascale Tomasini, Julie Egea, Maxime Souquet-Bressand, et al.
Bulletin Du Cancer
|
September 29, 2012
[β-Human chorionic gonadotropin (HCG) dosage and lung cancer: a pitfall when screening patients for clinical trials]
Nataliya Khobta, Pascale Tomasini, Marie-Eve Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 23, 2015
Tumor relapse after thoracic surgery?
Marie-Eve Garcia, Pascale Tomasini, Pascal Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 25, 2026
The evolving landscape of early-phase oncology: Toward more precise drug development
Camille Mazza, Matthieu Roulleaux Dugage, Antoine Italiano, et al.
Psychology, Health & Medicine
|
February 18, 2020
Illness representations and quality of life in French patients suffering from lung cancer
Nathalie Masson, Lionel Dany, Patrice Cannone, et al.
World Neurosurgery
|
August 14, 2017
Bevacizumab Plus Radiosurgery for Nonsquamous Non-Small Cell Lung Cancer Patients with Brain Metastases: Safe Combination?
Julien Guinde, Romain Carron, Pascale Tomasini, et al.
Page
of 35
Search research articles
Search
Showing results (41-50 of 344) with videos related to
Sort By:
Page
of 35
Expert Review of Anticancer Therapy
|
December 5, 2018
Therapeutic potential of trametinib to inhibit the mutagenesis by inactivating the protein kinase pathway in non-small cell lung cancer
Arnaud Jeanson, Arnaud Boyer, Laurent Greillier, et al.
Translational Cancer Research
|
February 4, 2022
First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer
Camille Travert, Pascale Tomasini, Arnaud Jeanson, et al.
Pharmaceutics
|
August 16, 2020
Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Guillaume Sicard, Frédéric Fina, Raphaelle Fanciullino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2015
Ang1 and Tie2 are predictive biomarkers for bevacizumab-letter
Joseph Ciccolini, Cindy Serdjebi, Dominique Barbolosi, et al.
Therapeutic Advances in Respiratory Disease
|
February 22, 2019
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases
Pascale Tomasini, Julie Egea, Maxime Souquet-Bressand, et al.
Bulletin Du Cancer
|
September 29, 2012
[β-Human chorionic gonadotropin (HCG) dosage and lung cancer: a pitfall when screening patients for clinical trials]
Nataliya Khobta, Pascale Tomasini, Marie-Eve Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 23, 2015
Tumor relapse after thoracic surgery?
Marie-Eve Garcia, Pascale Tomasini, Pascal Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 25, 2026
The evolving landscape of early-phase oncology: Toward more precise drug development
Camille Mazza, Matthieu Roulleaux Dugage, Antoine Italiano, et al.
Psychology, Health & Medicine
|
February 18, 2020
Illness representations and quality of life in French patients suffering from lung cancer
Nathalie Masson, Lionel Dany, Patrice Cannone, et al.
World Neurosurgery
|
August 14, 2017
Bevacizumab Plus Radiosurgery for Nonsquamous Non-Small Cell Lung Cancer Patients with Brain Metastases: Safe Combination?
Julien Guinde, Romain Carron, Pascale Tomasini, et al.
Page
of 35